Jul 31, 2024 / 12:00PM GMT
Operator
Hello. And welcome to the Teva Pharmaceuticals Industries Limited Q2 2024 earnings call. My name is Alex. And I'll be coordinating the call today. (Operator Instructions)
I'll now hand it over to your host, Ran Meir, SVP, Head of Investor Relations. Please go ahead.
Ran Meir - Teva Pharmaceutical Industries Ltd - Senior Vice President, Head of Investor Relations and Corporate Communications
Thank you, Alex. And thank you, everyone, for joining us today. We hope you have had a chance to review our Q2 results press release, which was issued earlier this morning. Copy of the press release, along with the slides presented during this call, are available on our website at ir.tevapharm.com.
Please review our forward-looking statements on slide 2. Additional information regarding these statements and the non-GAAP financial measures is available on our earnings release and in our SEC Forms 10-K and 10-Q.
To begin today's call, Richard Francis, Teva's CEO, will provide an overview of Teva's second quarter business performance, recent events,
Q2 2024 Teva Pharmaceutical Industries Ltd Earnings Call Transcript
Jul 31, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers